BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Maier I, Wu GY. Hepatitis C and HIV co-infection: A review. World J Gastroenterol 2002; 8(4): 577-579 [PMID: 12174359 DOI: 10.3748/wjg.v8.i4.577]
URL: https://www.wjgnet.com/1007-9327/full/v8/i4/577.htm
Number Citing Articles
1
José Américo Aquino, Katia Abrahim Pegado, Lílian Patrícia Barros, Luiz Fernando Almeida Machado. Soroprevalência de infecções por vírus da hepatite B e vírus da hepatite C em indivíduos do Estado do ParáRevista da Sociedade Brasileira de Medicina Tropical 2008; 41(4): 334 doi: 10.1590/S0037-86822008000400003
2
Md Mahbub Hossain, Nobonita Saha, Tahmina Tasnim Rodela, Samia Tasnim, Tasmiah Nuzhath, Tamal Joyti Roy, James N. Burdine, Helal Uddin Ahmed, E. Lisako J. McKyer, Banga Kamal Basu, Ping Ma. Global research on syndemics: a meta-knowledge analysis (2001-2020)F1000Research 2023; 11: 253 doi: 10.12688/f1000research.74190.2
3
Clyde B McCoy, Lisa R Metsch, Fernando Collado-Mesa, Kristopher L Arheart, Sarah E Messiah, Dolores Katz, Paul Shapshak. The prevalence of human immunodeficiency virus type 1 and hepatitis C virus among injection drug users who use high risk inner-city locales in Miami, FloridaMemórias do Instituto Oswaldo Cruz 2004; 99(8): 789 doi: 10.1590/S0074-02762004000800002
4
Nicole E. Skinner, Candelaria Vergara, Ramy El-Diwany, Harry Paul, Alyza Skaist, Sarah J. Wheelan, David L. Thomas, Stuart C. Ray, Ashwin Balagopal, Justin R. Bailey. Decreased Activated CD4+T Cell Repertoire Diversity After Antiretroviral Therapy in HIV-1/HCV Coinfection Correlates with CD4+T Cell RecoveryViral Immunology 2021; 34(9): 622 doi: 10.1089/vim.2021.0027
5
Yan-Heng Zhou, Feng-Liang Liu, Zhi-Hong Yao, Lin Duo, Hong Li, Yi Sun, Yong-Tang Zheng, Volker Thiel. Comparison of HIV-, HBV-, HCV- and Co-Infection Prevalence between Chinese and Burmese Intravenous Drug Users of the China-Myanmar Border RegionPLoS ONE 2011; 6(1): e16349 doi: 10.1371/journal.pone.0016349
6
Natasha Beard, Andrew Hill. Combined “Test and Treat” Campaigns for Human Immunodeficiency Virus, Hepatitis B, and Hepatitis C: A Systematic Review to Provide Evidence to Support World Health Organization Treatment GuidelinesOpen Forum Infectious Diseases 2024; 11(2) doi: 10.1093/ofid/ofad666
7
Alexandra Nieters, Birgit Kallinowski, Paul Brennan, Melanie Ott, Marc Maynadié, Yolanda Benavente, Lenka Foretova, Pier Luigi Cocco, Anthony Staines, Martine Vornanen, Denise Whitby, Paolo Boffetta, Nikolaus Becker, Silvia De Sanjosé. Hepatitis C and Risk of Lymphoma: Results of the European Multicenter Case-Control Study EPILYMPHGastroenterology 2006; 131(6): 1879 doi: 10.1053/j.gastro.2006.09.019
8
Isabelle J. H. Foo, Brendon Y. Chua, So Young Chang, Xiaoxiao Jia, Alice van der Eerden, John K. Fazakerley, Katherine Kedzierska, Lukasz Kedzierski, Stacey Schultz-Cherry. Prior influenza virus infection alleviates an arbovirus encephalitis by reducing viral titer, inflammation, and cellular infiltrates in the central nervous systemJournal of Virology 2025; 99(2) doi: 10.1128/jvi.02108-24
9
Yi-Biao Zhou, Song Liang, Qi-Xing Wang, Yu-Han Gong, Shi-Jiao Nie, Lei Nan, Ai-Hui Yang, Qiang Liao, Xiu-Xia Song, Qing-Wu Jiang. The geographic distribution patterns of HIV-, HCV- and co-infections among drug users in a national methadone maintenance treatment program in Southwest ChinaBMC Infectious Diseases 2014; 14(1) doi: 10.1186/1471-2334-14-134
10
David K. Henderson. Managing Occupational Risks for Hepatitis C Transmission in the Health Care SettingClinical Microbiology Reviews 2003; 16(3): 546 doi: 10.1128/CMR.16.3.546-568.2003
11
Hua-Zhang Guo, Ying Yin, Wen-Liang Wang, Chuan-Shan Zhang, Tao Wang, Zhe Wang, Jing Zhang, Hong Cheng, Hai-Tao Wang. Sequence evolution of putative cytotoxic T cell epitopes in NS3 region of hepatitis C virusWorld Journal of Gastroenterology 2004; 10(6): 847-851 doi: 10.3748/wjg.v10.i6.847
12
D. Silver, G. Karnik, A. Osinusi, R. Silk, L. Stabinski, L. Doonquah, S. Henn, G. Teferi, H. Masur, S. Kottilil, D. Fishbein. Effect of HIV on Liver Fibrosis Among HCV-Infected African AmericansClinical Infectious Diseases 2013; 56(9): 1280 doi: 10.1093/cid/cit037
13
Carlos Arturo Rojas Rodríguez, Angelica Tobon Guevara, Mauricio Sepulveda Copete, Nelson Rojas Rojas, Diego Fernando Jimenez Rivera. Hepatitis C: una aproximación clínica y epidemiológica en Cali, ColombiaRevista Colombiana de Gastroenterología 2018; 33(4): 379 doi: 10.22516/25007440.222
14
J. Stebbing, L. Waters, S. Mandalia, M. Bower, M. Nelson, B. Gazzard. Hepatitis C Virus Infection in HIV Type 1--Infected Individuals Does Not Accelerate a Decrease in the CD4+ Cell Count but Does Increase the Likelihood of AIDS-Defining EventsClinical Infectious Diseases 2005; 41(6): 906 doi: 10.1086/432885
15
Mai-Huong Thi Ngo, Han-Yin Jeng, Yung-Che Kuo, Josephine Diony Nanda, Ageng Brahmadhi, Thai-Yen Ling, Te-Sheng Chang, Yen-Hua Huang. The Role of IGF/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug ResistanceInternational Journal of Molecular Sciences 2021; 22(4): 1931 doi: 10.3390/ijms22041931
16
Pirapon June Ohata, Hay Mar Su Lwin, Win Min Han, Giten Khwairakpam, Pisit Tangkijvanich, Gail V Matthews, Anchalee Avihingsanon. Elimination of Hepatitis C Among HIV-positive Population in Asia: Old and New ChallengesFuture Virology 2021; 16(6): 407 doi: 10.2217/fvl-2021-0015
17
J. Alberto Juárez Navarro. Treatment of HCV and HIV coinfectionAnnals of Hepatology 2006; 5: S42 doi: 10.1016/S1665-2681(19)31971-4
18
Huseyin Gunduz, Oguz Karabay, Ali Tamer, Resat Özaras, Ali Mert, Ömer Fehmi Tabak. N-acetyl cysteine therapy in acute viral hepatitisWorld Journal of Gastroenterology 2003; 9(12): 2698-2700 doi: 10.3748/wjg.v9.i12.2698
19
Justin STEBBING, Steve PATTERSON, Simon PORTSMOUTH, Claire THOMAS, Robert GLASSMAN, Adrian WILDFIRE, Frances GOTCH, Mark BOWER, Mark NELSON, Brian GAZZARD. Studies on the allostimulatory function of dendritic cells from HCV-HIV-1 co-infected patientsCell Research 2004; 14(3): 251 doi: 10.1038/sj.cr.7290226
20
Beatrice Mukami Muriuki, Michael Muita Gicheru, Dorcas Wachira, Anthony Kebira Nyamache, Samoel Ashimosi Khamadi. Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, KenyaBMC Research Notes 2013; 6(1) doi: 10.1186/1756-0500-6-363
21
Noha H. Farag, Hebat‐Allah Rashed, Magda Hassan, Alaa Darweesh, Mohamed Shehata, Tarek Hassanein, Paul J. Mills. Hepatitis C infection, Cognition, and inflammation in an Egyptian sampleJournal of Medical Virology 2011; 83(2): 261 doi: 10.1002/jmv.21879
22
Seng-Lai Tan, Arnim Pause, Yuguang Shi, Nahum Sonenberg. Hepatitis C therapeutics: current status and emerging strategiesNature Reviews Drug Discovery 2002; 1(11): 867 doi: 10.1038/nrd937
23
Shaodong Ye, Lin Pang, Xiaochun Wang, Zhongfu Liu. Epidemiological Implications of HIV-Hepatitis C Co-Infection in South and Southeast AsiaCurrent HIV/AIDS Reports 2014; 11(2): 128 doi: 10.1007/s11904-014-0206-z
24
Edison Mayanja, Livingstone S. Luboobi, Juma Kasozi, Rebecca N. Nsubuga, Raul Alcaraz. Mathematical Modelling of HIV-HCV Coinfection Dynamics in Absence of TherapyComputational and Mathematical Methods in Medicine 2020; 2020: 1 doi: 10.1155/2020/2106570
25
Brent Wise, Renan Castillo, Manjari Joshi, Robert V. O’Toole. Will My Fracture Surgery Get Infected? Evidence-based Risk FactorsTechniques in Orthopaedics 2020; 35(2): 100 doi: 10.1097/BTO.0000000000000421
26
Md Mahbub Hossain, Nobonita Saha, Tahmina Tasnim Rodela, Samia Tasnim, Tasmiah Nuzhath, Tamal Joyti Roy, James N. Burdine, Helal Uddin Ahmed, E. Lisako J. McKyer, Banga Kamal Basu, Ping Ma. Global research on syndemics: a meta-knowledge analysis (2001-2020)F1000Research 2022; 11: 253 doi: 10.12688/f1000research.74190.1
27
Veronna Marie, Johnson Lin. Viruses in the environment – presence and diversity of bacteriophage and enteric virus populations in the Umhlangane River, Durban, South AfricaJournal of Water and Health 2017; 15(6): 966 doi: 10.2166/wh.2017.066
28
Seema N. Desai, Jennifer L. Dodge, Alan L. Landay, Marshall J. Glesby, Patricia S. Latham, Maria C. Villacres, Audrey L. French, Stephen J. Gange, Ruth M. Greenblatt, Marion G. Peters. Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjectsMedicine 2016; 95(33): e4483 doi: 10.1097/MD.0000000000004483
29
Vinod V. S, Vijithkumar K, Riyas C, Malini V. S, Arun S. Menon. A Study on the Role of N-Acetyl Cysteine Therapy in Acute Viral Hepatitis AJournal of Evidence Based Medicine and Healthcare 2020; 7(22): 1068 doi: 10.18410/jebmh/2020/231
30
Vali Musazadeh, Arash Karimi, Nasim bagheri, Jaber Jafarzadeh, Sarvin Sanaie, Mahdi Vajdi, Mozhde Karimi, Hamid Reza Niazkar. The favorable impacts of silibinin polyphenols as adjunctive therapy in reducing the complications of COVID-19: A review of research evidence and underlying mechanismsBiomedicine & Pharmacotherapy 2022; 154: 113593 doi: 10.1016/j.biopha.2022.113593
31
Michael L. Tapper, Eric S. Daar, Peter J. Piliero, Kimberly Smith, Corklin Steinhart. Strategies for Initiating Combination Antiretroviral TherapyAIDS Patient Care and STDs 2005; 19(4): 224 doi: 10.1089/apc.2005.19.224
32
Yu-Hua Ruan, Kun-Xue Hong, Shi-Zhu Liu, Yi-Xin He, Feng Zhou, Guan-Ming Qin, Kang-Lin Chen, Hui Xing, Jian-Ping Chen, Yi-Ming Shao. Community-based survey of HCV and HIV coinfection in injection drug abusers in Sichuan Province of ChinaWorld Journal of Gastroenterology 2004; 10(11): 1589-1593 doi: 10.3748/wjg.v10.i11.1589
33
Priti Devi, Rajesh Pandey. Pathogens and Environmental Impact on Life Forms2024; : 127 doi: 10.1007/978-3-031-70088-0_7
34
Corey Saraceni, John Birk. A Review of Hepatitis B Virus and Hepatitis C Virus ImmunopathogenesisJournal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2020.00095
35
Ruth O. Adekunle, Rebecca Zhang, Zhengsheng Wang, Rachel E. Patzer, Aneesh K. Mehta. Early steps to kidney transplantation among persons with HIV and end‐stage renal disease in ESRD network 6Transplant Infectious Disease 2022; 24(1) doi: 10.1111/tid.13767
36
Mark L Willenbring. Integrating care for patients with infectious, psychiatric, and substance use disorders: concepts and approachesAIDS 2005; 19(Suppl 3): S227 doi: 10.1097/01.aids.0000192094.84624.c2
37
Sílvia M. Corvino, Rita M.S. Henriques, Rejane M.T. Grotto, Maria Inês de M.C. Pardini. Co-infecção HIV/HCV em pacientes de Botucatu e regiãoRevista Brasileira de Epidemiologia 2007; 10(4): 537 doi: 10.1590/S1415-790X2007000400012
38
N. A. Belyakov, B. B. Rassokhin, E. V. Boeva, L. V. Gutova, N. B. Khalezova, T. A. Stasishkis, A. Yu. Kovelenov, S. L. Plavinskiy. WOMEN CO-INFECTED WITH HIV AND VHC. PART 2. CLINICAL STATUS AND READINESS TO ANTIVIRAL THERAPYHIV Infection and Immunosuppressive Disorders 2019; 10(4): 57 doi: 10.22328/2077-9828-2018-10-4-57-66
39
Caterina Sagnelli, Salvatore Martini, Mariantonietta Pisaturo, Giuseppe Pasquale, Margherita Macera, Rosa Zampino, Nicola Coppola, Evangelista Sagnelli. Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impactWorld Journal of Hepatology 2015; 7(24): 2510-2521 doi: 10.4254/wjh.v7.i24.2510
40
Allison Dormanesh, Judy Huei-yu Wang, Ranit Mishori, Paula Cupertino, Joshua Longcoy, Seble Kassaye, Linda Kaljee, Coleman Smith, Christopher A. Loffredo. Adherence to clinical follow-up recommendations for liver function tests: A cross-sectional study of patients with HCV and their associated risk behaviorsPreventive Medicine Reports 2021; 23: 101482 doi: 10.1016/j.pmedr.2021.101482
41
Haleh Bagheri, Atoussa Fouladi, Karl Barange, Maryse Lapeyre‐Mestre, Jean‐Louis Payen, Jean Louis Montastruc, Jean‐Pierre Vinel. Follow‐up of Adverse Drug Reactions from Peginterferon alfa‐2b—Ribavirin TherapyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2004; 24(11): 1546 doi: 10.1592/phco.24.16.1546.50947
42
Wang AiPing, Wen ChunYang, Gao Fang. Efficacy of combination therapy of interferon-α and ribavirin for HIV/HCV co-infected patients in a six-year follow-upProceedings 2011 International Conference on Human Health and Biomedical Engineering 2011; : 171 doi: 10.1109/HHBE.2011.6027926
43
Laura Waters, Justin Stebbing, Sundhiya Mandalia, Anne Marie Young, Mark Nelson, Brian Gazzard, Mark Bower. Hepatitis C infection is not associated with systemic HIV‐associated non‐hodgkin's lymphoma: A cohort studyInternational Journal of Cancer 2005; 116(1): 161 doi: 10.1002/ijc.20988
44
Lydia M. Petrovic. HIV/HCV co‐infection: histopathologic findings, natural history, fibrosis, and impact of antiretroviral treatment: a review articleLiver International 2007; 27(5): 598 doi: 10.1111/j.1478-3231.2007.01478.x
45
D. SIMON, R. T. MICHITA, J. U. BÉRIA, D. C. TIETZMANN, A. T. STEIN, V. R. LUNGE. Alcohol misuse and illicit drug use are associated with HCV/HIV co-infectionEpidemiology and Infection 2014; 142(12): 2616 doi: 10.1017/S0950268814000041
46
Ahmed M. Fahmy, Muhammed S. Hammad, Mai S. Mabrouk, Walid I. Al-atabany. On leveraging self-supervised learning for accurate HCV genotypingScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-64209-y
47
Sana Mansha, Muhammad Imran, Amir Miraj Ul Hussain Shah, Muhsin Jamal, Fayyaz Ahmed, Muhammad Atif, Muhammmad Saleem, Sher Zaman Safi, Zareen Fatima, Ahmed Bilal Waqar. Hepatitis B and C Virus Infections Among Human Immunodeficiency Virus-Infected People Who Inject Drugs in Lahore, PakistanViral Immunology 2017; 30(5): 366 doi: 10.1089/vim.2016.0144
48
Yi-Biao Zhou, Qi-Xing Wang, Song Liang, Yu-Han Gong, Mei-xia Yang, Shi-Jiao Nie, Lei Nan, Ai-Hui Yang, Qiang Liao, Yang Yang, Xiu-Xia Song, Qing-Wu Jiang, Wenzhe Ho. HIV-, HCV-, and Co-Infections and Associated Risk Factors among Drug Users in Southwestern China: A Township-Level Ecological Study Incorporating Spatial RegressionPLoS ONE 2014; 9(3): e93157 doi: 10.1371/journal.pone.0093157
49
Mohamed A Daw, Abdallah El-Bouzedi, Aghnaya A Dau. Geographic distribution of HCV genotypes in Libya and analysis of risk factors involved in their transmissionBMC Research Notes 2015; 8(1) doi: 10.1186/s13104-015-1310-x
50
Milos Opravil, Joe Sasadeusz, David A Cooper, Jürgen K Rockstroh, Nathan Clumeck, Bonaventura Clotet, Julio Montaner, Francesca J Torriani, Jean DePamphilis, Douglas T Dieterich. Effect of Baseline CD4 Cell Count on the Efficacy and Safety of Peginterferon Alfa-2a (40KD) Plus Ribavirin in Patients With HIV/Hepatitis C Virus CoinfectionJAIDS Journal of Acquired Immune Deficiency Syndromes 2008; 47(1): 36 doi: 10.1097/QAI.0b013e31815ac47d
51
Laurie L. Kenney, Markus Cornberg, Alex T. Chen, Sebastien Emonet, Juan Carlos de la Torre, Liisa K. Selin, S. Perlman. Increased Immune Response Variability during Simultaneous Viral Coinfection Leads to Unpredictability in CD8 T Cell Immunity and PathogenesisJournal of Virology 2015; 89(21): 10786 doi: 10.1128/JVI.01432-15
52
Ching-Hsuan Liu, Alagie Jassey, Hsin-Ya Hsu, Liang-Tzung Lin. Antiviral Activities of Silymarin and DerivativesMolecules 2019; 24(8): 1552 doi: 10.3390/molecules24081552
53
Clara Fleiz, David Fajardo-Chica, Jorge Villatoro, María Elena Medina-Mora. Opioids2022; : 105 doi: 10.1007/978-3-031-09936-6_6
54
Anita Kohli, Emily Funk, Peter Burbelo, Lisa Barrett, Eric G. Meissner, Brian Santich, Ashton Shaffer, Jessica Johl, Sreetha Sidharthan, Susan Moir, Shyam Kottilil, Anthony S. Fauci. Persistently elevated abnormal B‐cell subpopulations and anti‐core antibodies in patients co‐infected with HIV/HCV who relapseJournal of Medical Virology 2015; 87(4): 544 doi: 10.1002/jmv.24089
55
Priscila O Barros, Tamara K Berthoud, Nawaf Aloufi, Jonathan B Angel. Soluble IL-7Rα/sCD127 in Health, Disease, and Its Potential Role as a Therapeutic AgentImmunoTargets and Therapy 2021; : 47 doi: 10.2147/ITT.S264149